malondialdehyde has been researched along with gw9662 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, D; Yao, SL; Zeng, BX; Zhang, SH | 1 |
Kobara, M; Nakata, T; Noda, K; Toba, H; Tojo, C; Wang, J | 1 |
Eslami, H; Rahati, M; Rahimi, H; Sharifi, AM | 1 |
Cui, Y; Deng, M; Qi, ZG; Shang, X; Wang, XL; Xie, ML; Xue, J; Zhang, Y; Zhao, X | 1 |
Askari, VR; Mousavi, SH; Rahimi, VB | 1 |
Askari, VR; Baradaran Rahimi, V; Mousavi, SH | 1 |
6 other study(ies) available for malondialdehyde and gw9662
Article | Year |
---|---|
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Blotting, Western; Chemokine CXCL1; Chemokines, CXC; Endotoxemia; Immunohistochemistry; Intercellular Adhesion Molecule-1; Intercellular Signaling Peptides and Proteins; Lipid Peroxidation; Lung; Male; Malondialdehyde; Neutrophil Infiltration; NF-kappa B; Peroxidase; Pneumonia; PPAR gamma; Pulmonary Edema; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2005 |
Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Aorta; Benzimidazoles; Benzoates; Blood Urea Nitrogen; Disease Models, Animal; Inflammation; Kidney Failure, Chronic; Losartan; Male; Malondialdehyde; Nephrectomy; PPAR gamma; Rats; Rats, Wistar; Telmisartan; Vasodilation | 2012 |
Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell.
Topics: Angiotensin II Type 2 Receptor Blockers; Anilides; Animals; Antioxidants; Apoptosis; Benzimidazoles; Benzoates; Catalase; Cell Survival; Glucose; Glutathione; Malondialdehyde; NADP; Neuroprotective Agents; Oxidative Stress; PC12 Cells; PPAR gamma; Rats; Reactive Oxygen Species; Superoxide Dismutase; Telmisartan | 2014 |
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Topics: Anilides; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Fatty Acids, Nonesterified; Fenofibrate; Gene Expression Regulation; Glutathione; Indoles; Inflammation; Interleukin-6; Interleukin-8; Lipid Metabolism; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Ellagic acid reveals promising anti-aging effects against d-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: A mechanistic study.
Topics: Aging; Anilides; beta-Galactosidase; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Ellagic Acid; Galactose; Glutathione; Glycation End Products, Advanced; Humans; Malondialdehyde; Mannitol; Metformin; Neuroblastoma; Protoporphyrins; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2018 |
Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: Investigating the role of PPAR-γ.
Topics: Aging; Anilides; Animals; Apoptosis; Brain; Ellagic Acid; Galactose; Glutathione Peroxidase; Liver; Male; Malondialdehyde; Metformin; Mice; Models, Animal; Oxidative Stress; PPAR gamma; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |